Does hyperthermic intraperitoneal chemotherapy influencethe rate of infective complications and change the patternof infectious agents in patients undergoing cytoreductivesurgery for peritoneal carcinomatosis?

Abstract

Aim: When CRS, in which complex surgical procedures are applied combined with HIPEC in which high dose cytotoxic agents areapplied, many serious postoperative complications, especially infection-related complications, may develop in the patient groupwith peritoneal carcinomatosis whose general condition is impaired. In this study, it was aimed to investigate the effect of HIPECapplication after SRC on infection rates and microbial agent spectrum alone. Materials and Methods: Between January 2012 and January 2020, one thousand six hundreds forty eight patients diagnosed withperitoneal carcinomatosis were scanned from hospital database and two hundred thirty-five eligible patients were included in thestudy. Demographic and clinical data, perioperative results and culture results were analyzed by grouping the patients as HIPEC andnon-HIPEC. Results : It has been found that the incidence of surgical site infections was significantly higher in HIPEC group. (23.6%vs11.5%p=0.011). When the culture results were analyzed. The number of patients with E.coli (13.7% vs 5.7% p = 0.001), Klebsiella pneumoniae (9.9% vs2.8% p = 0.001) and Pseudomonas aeruginosa (2.2% vs 0.9% p = 0.034) growth was significantly higher in the HIPEC group. Conclusions: It has been found that HIPEC application not only increases the infection rates but also expands the potential pathogenspectrum. Prediction of possible pathogens responsible for postoperative infections may affect the choice of prophylactic andultimate treatment and so the risk of developing morbidity and mortality which may result from a possible septic progression, canbe minimized with an effective antimicrobial therapy.